Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$88.61 USD
+0.86 (0.98%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $88.50 -0.11 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC4/25/24 |
---|---|
Current Quarter | 0.64 |
EPS Last Quarter | 0.64 |
Last EPS Surprise | 0.00% |
ABR | 2.16 |
Earnings ESP
|
1.02% |
---|---|
Current Year | 2.76 |
Next Year | 3.09 |
EPS (TTM) | 2.51 |
P/E (F1) | 31.79 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.58B | 1.64B | 6.51B | 7.14B |
# of Estimates | 12 | 12 | 12 | 12 |
High Estimate | 1.61B | 1.68B | 6.61B | 7.31B |
Low Estimate | 1.57B | 1.61B | 6.46B | 7.00B |
Year ago Sales | 1.46B | 1.53B | 6.00B | 6.51B |
Year over Year Growth Est. | 7.95% | 7.29% | 8.48% | 9.68% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.64 | 0.70 | 2.76 | 3.09 |
# of Estimates | 13 | 11 | 13 | 13 |
Most Recent Consensus | 0.65 | 0.71 | 2.75 | 3.11 |
High Estimate | 0.66 | 0.72 | 2.80 | 3.16 |
Low Estimate | 0.63 | 0.67 | 2.74 | 3.00 |
Year ago EPS | 0.62 | 0.66 | 2.51 | 2.76 |
Year over Year Growth Est. | 3.23% | 6.06% | 9.96% | 12.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 3 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.64 | 0.70 | 2.76 | 3.09 |
7 Days Ago | 0.64 | 0.70 | 2.76 | 3.10 |
30 Days Ago | 0.64 | 0.70 | 2.76 | 3.10 |
60 Days Ago | 0.64 | 0.70 | 2.76 | 3.09 |
90 Days Ago | 0.66 | 0.69 | 2.74 | 3.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.65 | 0.71 | 2.75 | 3.11 |
Zacks Consensus Estimate | 0.64 | 0.70 | 2.76 | 3.09 |
Earnings ESP | 1.02% | 1.25% | -0.36% | 0.58% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.64 | 0.59 | 0.66 | 0.62 | NA |
Estimate | 0.64 | 0.59 | 0.65 | 0.61 | NA |
Difference | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Surprise | 0.00% | 0.00% | 1.54% | 1.64% | 0.80% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more